More than half of the states in the country have voted for legalization of medical marijuana and cannabis programs. The industry’s reputation is becoming less stigmatized and more respectable as both the people and the methods involved transform. In three years, the industry is expected to explode nationally to $22 billion in market sales; by 2026, that number may exceed $50 billion. And because of states’ tight regulations, many entrepreneurs have had to adjust their approach from simply entering a niche market to strategizing meticulous business plans with similarly complex cultivation techniques — and garnered respect for simultaneously revolutionizing the industry.
Is that something we might champion in our region? That depends on two cruxes: Research and legislative phrasing.
So what does the research say?
The drug’s Schedule 1 classification means the FDA has found no health benefits to use. But according to the National Cancer Institute, human and animal research suggests it exhibits anti-inflammatory, antitumor and antiemetic properties. Some studies also demonstrate potential in alleviating anxiety, but a